Literature DB >> 14502192

High antithrombin III levels attenuate hemostatic activation and leukocyte activation during cardiopulmonary bypass.

Andreas Koster1, Derek Chew, Wolfgang Kuebler, Helmut Habazettl, Roland Hetzer, Herman Kuppe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14502192     DOI： 10.1016/s0022-5223(03)00392-1

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  3 in total

1.  Initial experience with recombinant antithrombin to treat antithrombin deficiency in patients on extracorporeal membrane oxygenation.

Authors:  Kevin S Niimi; Jeffrey J Fanning
Journal:  J Extra Corpor Technol       Date:  2014-03

2.  Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.

Authors:  Lukas Wettstein; Patrick Immenschuh; Tatjana Weil; Carina Conzelmann; Yasser Almeida-Hernández; Markus Hoffmann; Amy Kempf; Inga Nehlmeier; Rishikesh Lotke; Moritz Petersen; Steffen Stenger; Frank Kirchhoff; Daniel Sauter; Stefan Pöhlmann; Elsa Sanchez-Garcia; Jan Münch
Journal:  J Med Virol       Date:  2022-09-03       Impact factor: 20.693

3.  Pre-operative homocysteine levels and morbidity and mortality following cardiac surgery.

Authors:  Marco Ranucci; Andrea Ballotta; Alessandro Frigiola; Alessandra Boncilli; Simonetta Brozzi; Elena Costa; Rajendra H Mehta
Journal:  Eur Heart J       Date:  2009-02-17       Impact factor: 29.983
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.